By Matt Jones

NEW YORK (GenomeWeb News) – If the new technologies of the genomics era are going to be useful in addressing public health outcomes, steps should be taken to improve the evidence supporting their value, to educate the healthcare workforce and the public about their use, and to ensure their safety and effectiveness and applicability to chronic diseases, according to a report about the state of public health genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.